Status:
UNKNOWN
Prevention of Female Genital Schistosomiasis (FGS) in Rural High-endemic South Africa
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
University of KwaZulu
University of Agder
Conditions:
Uro-genital Schistosomiasis
Eligibility:
FEMALE
10-23 years
Brief Summary
Schistosomiasis is a poverty-related water-transmitted parasitic disease affecting more that 200 million people world wide. Infection with Schistosoma haematobium may cause Female Genital Schistosomia...
Detailed Description
Provide a more extensive description, if desired. Avoid duplication of information to be recorded elsewhere, such as eligibility criteria or outcome measures
Eligibility Criteria
Inclusion
- Females in Schistosoma haematobium endemic areas
Exclusion
- Boys
- Pregnancy
- Allergic to praziquantel
- Severe disease
Key Trial Info
Start Date :
April 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
6500 Patients enrolled
Trial Details
Trial ID
NCT01154907
Start Date
April 1 2010
End Date
December 1 2021
Last Update
September 19 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of KwaZulu Natal
Durban, KwaZulu-Natal, South Africa, 4000